Search Results - "Roumeliotou, Argyro"
-
1
PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC)
Published in Biomedicines (05-08-2022)“…The PD-1/PD-L1 axis provides CTCs an escape route from the immune system. Phosphorylation of the ribosomal protein S6 is implicated in the same pathway,…”
Get full text
Journal Article -
2
STIM1, ORAI1, and KDM2B in circulating tumor cells (CTCs) isolated from prostate cancer patients
Published in Frontiers in cell and developmental biology (05-06-2024)“…Previous publications have shown that STIM1, ORAI1, and KDM2B, are implicated in Ca signaling and are highly expressed in various cancer subtypes including…”
Get full text
Journal Article -
3
ES-SCLC Patients with PD-L1 + CTCs and High Percentages of CD8 + PD-1 + T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment
Published in Biomedicines (01-01-2024)“…SCLC is an aggressive cancer type with high metastatic potential and bad prognosis. CTCs are a valuable source of tumor cells in blood circulation and are…”
Get full text
Journal Article -
4
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients
Published in Cells (Basel, Switzerland) (01-05-2024)“…CXCR4, JUNB and PD-L1 are implicated in cancer progression and metastasis. The current study investigated these biomarkers in CTCs isolated from metastatic…”
Get full text
Journal Article -
5
Clinical Relevance of Mesenchymal- and Stem-Associated Phenotypes in Circulating Tumor Cells Isolated from Lung Cancer Patients
Published in Cancers (29-04-2021)“…Lung cancer is the leading cause of cancer-related mortality globally. Among the types of lung cancer, non-small-cell lung cancer (NSCLC) is more common, while…”
Get full text
Journal Article -
6
Integrative analysis of circulating tumor cells ( CTCs ) and exosomes from small‐cell lung cancer ( SCLC ) patients: a comprehensive approach
Published in Molecular oncology (22-11-2024)“…The increased metastatic ability of small‐cell lung cancer (SCLC) necessitates the identification of new prognostic biomarkers for clinical evaluation during…”
Get full text
Journal Article -
7
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients
Published in Cancers (28-12-2022)“…In the present study, we evaluated the expression of JUNB and CXCR4 in circulating tumor cells (CTCs) of lung cancer patients and investigated whether these…”
Get full text
Journal Article -
8
PD-L1/pS6 in Circulating Tumor Cells
Published in Biomedicines (01-08-2022)“…The PD-1/PD-L1 axis provides CTCs an escape route from the immune system. Phosphorylation of the ribosomal protein S6 is implicated in the same pathway,…”
Get full text
Journal Article -
9
Abstract 1966: Dr
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Background: According to recent publications of our group, JUNB and CXCR4 were overexpressed in CTCs and DTCs isolated from breast cancer patients. This…”
Get full text
Journal Article